1. Home
  2. ANIX vs ATLX Comparison

ANIX vs ATLX Comparison

Compare ANIX & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

SELL

Current Price

$2.68

Market Cap

114.0M

Sector

Health Care

ML Signal

SELL

Logo Atlas Lithium Corporation

ATLX

Atlas Lithium Corporation

HOLD

Current Price

$2.12

Market Cap

91.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
ATLX
Founded
1982
2011
Country
United States
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
91.2M
IPO Year
2013
2012

Fundamental Metrics

Financial Performance
Metric
ANIX
ATLX
Price
$2.68
$2.12
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $9.75
N/A
AVG Volume (30 Days)
★ 306.6K
260.1K
Earning Date
09-09-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
12.82
★ 47.08
EPS
★ N/A
N/A
Revenue
★ $210,000.00
$92,491.00
Revenue This Year
N/A
$8.12
Revenue Next Year
N/A
$217,536.00
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.32
$2.07
52 Week High
$5.46
$8.25

Technical Indicators

Market Signals
Indicator
ANIX
ATLX
Relative Strength Index (RSI) 39.55 26.78
Support Level $2.62 N/A
Resistance Level $3.09 $2.70
Average True Range (ATR) 0.14 0.15
MACD 0.01 -0.04
Stochastic Oscillator 7.17 9.76

Price Performance

Historical Comparison
ANIX
ATLX

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About ATLX Atlas Lithium Corporation

Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project, located in Minas Gerais State in Brazil. The company is focused on producing and selling lithium concentrate, a key ingredient for the battery supply chain.

Share on Social Networks: